Viewing Study NCT01458769


Ignite Creation Date: 2025-12-24 @ 11:02 PM
Ignite Modification Date: 2025-12-30 @ 10:50 AM
Study NCT ID: NCT01458769
Status: COMPLETED
Last Update Posted: 2013-05-24
First Post: 2011-06-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Pharmacokinetics, Safety & Tolerability of Isotopologs of Atazanavir (ATV), With Pharmacokinetic Comparison to Reyataz
Sponsor: Concert Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module